References
- HughesRAPeripheral neuropathyBMJ2002324733546646911859051
- MartynCNHughesRAEpidemiology of peripheral neuropathyJ Neurol Neurosurg Psychiatry19976243103189120441
- DyckPJOviattKFLambertEHIntensive evaluation of referred unclassified neuropathies yields improved diagnosisAnn Neurol19811032222267294727
- TothCAuSA prospective identification of neuropathic pain in specific chronic polyneuropathy syndromes and response to pharmacological therapyPain2008138365766618691815
- BackonjaMBeydounAEdwardsKRGabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trialJAMA199828021183118369846777
- GordonAChoiniereMColletJPThe humanistic burden of neuropathic pain in CanadaJournal of Outcomes Research200620062335
- MauskopfJAustinRDixLBerzonRThe Nottingham Health Profile as a measure of quality of life in zoster patients: convergent and discriminant validityQual Life Res1994364314357866361
- McDermottAMToelleTRRowbothamDJThe burden of neuropathic pain: results from a cross-sectional surveyEur J Pain200610212713516310716
- Meyer-RosbergKBurckhardtCSHuizarKA comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic painEur J Pain20015439140311743705
- BennettMISmithBHTorranceNPotterJThe S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal researchJ Pain20056314915815772908
- BouhassiraDAttalNAlchaarHComparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire(DN4)Pain20051141–2293615733628
- SindrupSHOttoMFinnerupNBJensenTSAntidepressants in the treatment of neuropathic painBasic Clin Pharmacol Toxicol200596639940915910402
- MoulinDEClarkAJGilronIPharmacological management of chronic neuropathic pain – consensus statement and guidelines from the Canadian Pain SocietyPain Res Manag2007121132117372630
- ChongMSHesterJDiabetic painful neuropathy: current and future treatment optionsDrugs200767456958517352515
- GilronIWatsonCPCahillCMMoulinDENeuropathic pain: a practical guide for the clinicianCMAJ2006175326527516880448
- BackonjaMMGabapentin monotherapy for the symptomatic treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitusEpilepsia199940Suppl 6S57S5910530684
- DallocchioCBuffaCMazzarelloPChiroliSGabapentin vs amitriptyline in painful diabetic neuropathy: an open-label pilot studyJ Pain Symptom Manage200020428028511027910
- GilronIBaileyJMTuDMorphine, gabapentin, or their combination for neuropathic painN Engl J Med2005352131324133415800228
- SindrupSHJensenTSEfficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug actionPain199983338940010568846
- GoldsteinDJLuYDetkeMJDuloxetine vs. placebo in patients with painful diabetic neuropathyPain20051161–210911815927394
- RaskinJPritchettYLWangFA double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic painPain Med20056534635616266355
- SindrupSHBachFWMadsenCVenlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trialNeurology20036081284128912707430
- RowbothamMCGoliVKunzNRLeiDVenlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled studyPain2004110369770615288411
- KhalifaMDaleauPTurgeonJMechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytesJ Pharmacol Exp Ther1999291128028410490914
- SumptonJEMoulinDETreatment of neuropathic pain with venlafaxineAnn Pharmacother200135555755911346061
- SimpsonDAGabapentin and venlafaxine for the treatment of painful diabetic neuropathyJ Clin Neuromuscul Dis200132536219078655
- MuthEAMoyerJAHaskinsJTBiochemical, neurophysiological, and behavioral effects of Wy-45,233 and other identified metabolites of the antidepressant venlafaxineDrug Dev Res200423191199
- BrilVPerkinsBAValidation of the Toronto Clinical Scoring System for diabetic polyneuropathyDiabetes Care200225112048205212401755
- PerkinsBAOlaleyeDZinmanBBrilVSimple screening tests for peripheral neuropathy in the diabetes clinicDiabetes Care200124225025611213874
- EnglandJDGronsethGSFranklinGEvaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review)Muscle Nerve200939111612519086068
- EnglandJDGronsethGSFranklinGDistal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and RehabilitationNeurology200564219920715668414
- TothCLanderJWiebeSThe prevalance and impact of chronic pain with neuropathic pain symptoms in the general populationPain Med200910591892919594844
- KindPDolanPGudexCWilliamsAVariations in population health stuatus: results from a United Kingdom national questionnaire surveyBMJ19983167367419529408
- HaysRDStewartALSleep measuresStewartALWareJEMeasuring Functioning and Well-being: The Medical Outcomes Study ApproachDurham, NCDuke University Press1992235259
- ZigmondASSnaithRPThe hospital anxiety and depression scaleActa Psychiatr Scand19836763613706880820
- AttalNCruccuGHaanpaaMEFNS guidelines on pharmacological treatment of neuropathic painEur J Neurol200613111153116917038030
- BackonjaMBeydounAEdwardsKRGabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trialJAMA199828021183118369846777
- GoldsteinDJLuYDetkeMJEffects of duloxetine on painful physical symptoms associated with depressionPsychosomatics2004451172814709757
- ArnoldLMLuYCroffordLJA double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorderArthritis Rheum20045092974298415457467
- ArnoldLMRosenAPritchettYLA randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorderPain20051191–351516298061
- RussellIJMeasePJSmithTREfficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trialPain2008136343244418395345
- MillanMJDescending control of painProg Neurobiol200266635547412034378